Clinical trial
Olmesartan and an add-on Treatment in Patients With Mild to Moderate…
NCT00311155 · Sankyo Pharma Gmbh, Industry · Completed
Key facts
| NCT number | NCT00311155 |
|---|---|
| Title | Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension |
| Official title | Treat-to-Target Study of Olmesartan Medoxomil and an Add-on Treatment Algorithm Consisting of Hydrochlorothiazide and Amlodipine Besylate in Patients With Mild to Moderate Hypertension |
| Acronym | OLMETREAT |
| Lead sponsor | Sankyo Pharma Gmbh, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Essential Hypertension |
| Intervention type | Drug |
| Interventions | olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary |
| Enrollment | 694 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Apr 5, 2006 |
| Last update posted | Dec 10, 2010 |
| Countries | Austria, Belgium, France, Germany, Italy, Netherlands, Portugal, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: